4.2 Article

Encapsulating Peritoneal Sclerosis in a Patient Receiving Peritoneal Dialysis and Glucocorticoid Therapy

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Proposal of peritoneal biopsy procedures for patients undergoing peritoneal dialysis

Tohru Mizumasa et al.

RENAL REPLACEMENT THERAPY (2020)

Article Urology & Nephrology

TNF SIGNALING IN PERITONEAL MESOTHELIAL CELLS: PIVOTAL ROLE OF cFLIPL

Willie M. Luedemann et al.

PERITONEAL DIALYSIS INTERNATIONAL (2017)

Article Urology & Nephrology

LENGTH OF TIME ON PERITONEAL DIALYSIS AND ENCAPSULATING PERITONEAL SCLEROSIS - POSITION PAPER FOR ISPD: 2017 UPDATE

Edwina A. Brown et al.

PERITONEAL DIALYSIS INTERNATIONAL (2017)

Article Urology & Nephrology

Peritoneal Effluent MMP-2 and PAI-1 in Encapsulating Peritoneal Sclerosis

Deirisa Lopes Barreto et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2015)

Article Engineering, Biomedical

Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution

Chieko Hamada et al.

JOURNAL OF ARTIFICIAL ORGANS (2015)

Article Urology & Nephrology

Peritoneal Solute Transport and Inflammation

Simon J. Davies

AMERICAN JOURNAL OF KIDNEY DISEASES (2014)

Article Urology & Nephrology

Independent Effects of Systemic and Peritoneal Inflammation on Peritoneal Dialysis Survival

Mark Lambie et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)

Letter Transplantation

Differential effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis

R Rajani et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)

Letter Transplantation

Corticosteroid therapy in encapsulating peritoneal sclerosis

S Kuriyama et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)